Navigation Links
AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
Date:12/9/2008

cg or 15mcg of sufentanil. Doses were delivered sublingually as needed to treat pain with a 20-minute minimum re-dosing interval and patients were allowed to drop out of the study at any time. Positive results were also obtained for the primary endpoint following treatment with the 15mcg dose compared to placebo using two alternate methods for imputing missing data from drop-outs: baseline observation carried forward (BOCF), p = 0.007, and last observation carried forward (LOCF), p = 0.018. Importantly, there were no events of clinically significant respiratory depression for any dosing group. Based on these positive results, AcelRx intends to further advance clinical development of ARX-01 in 2009.

"We are pleased by the wonderful clinical results of our Phase 2 post-operative acute pain study," said Thomas A. Schreck, chairman and chief executive officer of AcelRx Pharmaceuticals. "This is the culmination of a great deal of hard work by a team of efficient, dedicated people over the last two years, and is therefore very gratifying indeed. This trial has the benefit of validating Sublingual Sufentanil NanoTabs as a robust product candidate for its initial in-hospital acute pain indication, as well as providing the foundation of safety and efficacy for the other programs in our pipeline."

About ARX-01 Sublingual Sufentanil NanoTabs

Sufentanil is currently approved as an intravenous (IV) anesthetic and is also indicated for epidural administration during labor and delivery. Due to their small size, ARX-01 Sublingual Sufentanil NanoTabs are convenient, well-tolerated, have high bioavailability and provide lower peak plasma levels compared to IV administration.

About the ARX-01 Oral Patient-Controlled Analgesia System

The ARX-01 Oral Patient-Controlled Analgesia (PCA) system is based on a proprietary pre-programmed, hand-held dispenser being developed by AcelRx. The AcelRx d
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... BOSTON , June 17, 2013 ... billion by 2018, accounting for nearly 16 percent of total ... Drug Report 2013 from Evaluate .   ... this growing segment of the pharmaceutical industry, Evaluate has enhanced ... fact-based orphan drug analysis with data fields for integrated US, ...
(Date:6/17/2013)... CLEVELAND , June 17, 2013 ... healthcare organizations in the country, recovered more than ... with the help of OnBase, Hyland Software,s ... with Hyland to provide a common revenue cycle ... billing systems that were in place for both ...
(Date:6/17/2013)... 2013 Research and ... addition of the "North America Injectable ... Microspheres, & Nanoparticles], Devices [Disposables & Reusable, ... Auto Injectors] & Therapeutics- Forecasts to 2017" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ...
(Date:6/17/2013)... BEIJING , June 17, 2013 Yongye ... a leading developer, manufacturer, and distributor of crop nutrient ... ("PRC"), announced today that its common stock ... Monday, June 17, 2013 at 7:15 a.m. Eastern Time. ... Yongye,s common stock on Monday, March 18, 2013 following ...
Breaking Biology Technology:Evaluate Launches Enhanced Orphan Drug Intelligence 2Evaluate Launches Enhanced Orphan Drug Intelligence 3Cedars-Sinai Medical Center Recovers More Than $300 million in AR with Hyland Software's OnBase 2Cedars-Sinai Medical Center Recovers More Than $300 million in AR with Hyland Software's OnBase 3North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 2North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 2Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 4
... , , KNOXVILLE and OAK ... Ridge Innovation Valley ( www.knoxvilleoakridge.com ) see the successful test of ... , The Innovation Valley is home to Oak Ridge National Laboratory ... at the forefront of applied carbon fiber research. , ...
... NEW YORK, Dec. 18 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. ... a pharmaceutical,company dedicated to improving health through the development, ... over the counter ("OTC"),products, today announced that 158 of ... Insurance Catalog (the "2009 NIC"). Of these, 82,are categorized ...
... Department of Energy,s Pacific Northwest National Laboratory have ... the Advancement of Science for their exceptional efforts ... PNNL honorees and the AAAS sections that elected ... Yuehe Lin, chemistry; Philip Rasch, atmospheric and hydrospheric ...
Cached Biology Technology:Boeing Flight Boosts Carbon Fiber Hopes, Knoxville-Oak Ridge Innovation Valley Poised 2Boeing Flight Boosts Carbon Fiber Hopes, Knoxville-Oak Ridge Innovation Valley Poised 3American Oriental Bioengineering Announces the Inclusion of 158 Drugs in China's National Insurance Catalog 2American Oriental Bioengineering Announces the Inclusion of 158 Drugs in China's National Insurance Catalog 36 PNNL scientists elected AAAS fellows 26 PNNL scientists elected AAAS fellows 3
(Date:6/17/2013)... University research associate has received a prestigious fellowship to ... the spread of malaria. , Bart Bryant, research associate ... National Research Service Award Individual Postdoctoral Fellowship, which provides ... State University researcher to receive the award and is ... an award. , Bryant, a university doctoral graduate in ...
(Date:6/17/2013)... populations are declining worldwide and a major cause is ... but a two-year study shows they can also die ... a tolerant carrier host that just spreads the disease. ... controlled experimental conditions, they found at least one strain ... Bd or a chytrid fungus, can be fatal to ...
(Date:6/16/2013)... for female sex workers in India reduce rates of ... University of Toronto study has found. , ... in the southern states of Andhra Pradesh, Karnataka, Maharashtra ... Jha from U of T,s Dalla Lana School of ... Health Research (CGHR), examined the impact of prevention among ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2HIV prevention among female sex workers in India reduces HIV and syphilis 2
... polymers (LCP) as a viable tool for use in ... of Alberta researchers, collaborating with colleagues at the Eindhoven ... Netherlands, have shown that LCP, when formed into a ... and patterned on a microscale. The research was published ...
... cell fate decisions for many types of developing cells, according to ... sheds light on a puzzling behavior. For some differentiating stem ... to a new choice. In response to the initial ... different cell types. It often requires a second signal for ...
... with a single injection into a vein holds promise ... University of Florida researchers report. , UF researchers used ... a form of muscular dystrophy that damages the heart. ... and found genes were readily absorbed by heart muscle ...
Cached Biology News:Polymers show promise for lab-on-a-chip technology 2Researchers map out networks that determine cell fate 2Researchers map out networks that determine cell fate 3UF scientists test improved gene therapy method for hereditary heart conditions 2UF scientists test improved gene therapy method for hereditary heart conditions 3UF scientists test improved gene therapy method for hereditary heart conditions 4
... Columns, 10. *SizeSep 400 Spun Columns: For ... pairs in length. - ... in distilled water containing 0.15% Kathon CG/IcP Biocide. ... base pairs. *Extremely useful in the ...
... Light Diagnostics Universal Amplicon Detection ... use in the qualitative detection ... by in vitro nucleic ... only; not to be used ...
... Purification Kit, 25 purifications. Allows ... probesProvides efficient removal of unincorporated CyDye ... with superior yields of labeled cDNA ... of cDNA labeled by either direct ...
... Kit, 50 purifications. Allows rapid purification ... removal of unincorporated CyDye label and ... yields of labeled cDNA probe. ... labeled by either direct incorporation or ...
Biology Products: